Abstract:Abstract Objective To assess the effects of trans-tricuspid placement of permanent pacemaker (PPM), on the right-sided heart function and tricuspid valve function. Background Over the last decade there has been a significant increase in the number of cardiac device implantation as permanent pacemakers (PPM) worldwide in patients with cardiac rhythm disorders. Tricuspid regurgitation (TR) due to the endocardial lead is a known complication of this procedure, however the incidence of new or worsening TR had not been well studied. Patients and Methods We reviewed patients who underwent permanent pacemaker implantation in our cardiology department in Ain Shams University. Patients who had pacemaker implantation less than one year ago, had severe tricuspid regurgitation before implantation or had previous tricuspid valve repair were excluded. A total of one hundred patients with an echocardiographic study before and another echocardiographic study at least one year after device implantation were included in our study. TR severity was graded as (0 none/trace, 1 mild, 2 moderate, 3 severe). Results Of the 100 patients (Mean age: 53.10 ± 16.04, 50% of patients were males) 65 had DDD and 35 had VVI. Before implantation 25 patient had trace TR (grade 0) vs. 6 patients after, 75 patients had mild TR (grade 1) vs. 82 after, with no patient had moderate TR (grade 2) vs. 12 patients after. TR worsened by one grade in 25 patients, (16 patients from grade 0 to grade 1 and 9 patients from grade 1 to grade 2) and by 2 grades in 3 patients (from grade 0 to grade 2), Pvalue < 0.01. TR jet area size (Mean ± SD: 2.80 ± 0.77 before vs. 4.15 ± 1.29 after, P-value < 0.01). Also, 99 patients had normal RV size and one had dilated RV before implantation vs. 95 patient had normal RV and 5 had dilated RV (p-value= 0.097). RV size, LVEF (Mean ± SD: 56.41% ± 7.52 before vs. 55.77% ± 8.00 after), RV function by TASPE (Mean ± SD: 19.15 ± 1.00 before vs. 18.96 ± 0.96 after), RVSP (Mean ± SD: 29.48mmHg ± 5.54 before vs. 29.81 ± 5.09 after) and diastolic function by E/A ratio (Mean ± SD: 1.60 ± 0.39 before vs. 1.57 ± 0.38 after implantation) did not show significant change. Conclusion Permanent pacemaker (PPM) implantation is associated with worsening of tricuspid regurgitation. Echocardiography plays an important role in assessing and grading this condition. Further studies are needed in order to illustrate the effects of these finding on patients outcomes.

Assessment of the effects of cardiac rhythm device implantation on right sided heart function and tricuspid valve

Cardiac Pacemaker and the Effect on Hemodynamics of the Tricuspid Valve

Effect of electronic device implantation on tricuspid valve function

Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta‐analysis

Tricuspid Valve Regurgitation Following Temporary or Permanent Endocardial Lead Insertion, and the Impact of Cardiac Resynchronization Therapy

Tricuspid regurgitation burden following transcatheter aortic valve replacement requiring early pacemaker implantation

Association Between Cardiovascular Implantable Electronic Devices and Tricuspid Regurgitation: a Case-Control Study.

Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis

Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design

Association of late tricuspid regurgitation progression and intracardiac lead types in patients after primary implantation of cardiac electronic devices

Factors Associated with Permanent Pacemaker Placement After Tricuspid Valve Operations

Abstract 15350: Differing Impacts of Cardiac Implantable Electronic Device Leads on Tricuspid Regurgitation

Abstract 12929: Pacemaker Lead-induced Tricuspid Regurgitation in Patients With or Without RV Dilatation

Phenotype of severe tricuspid regurgitation induced by intracardiac pacing devices

Incidence, time course, and outcomes of worsening tricuspid regurgitation following transvenous cardiac implantable electronic device implantation

Incidence and risk factors for permanent pacemaker implantation in patients undergoing tricuspid valve surgery

Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Population.

Tricuspid Regurgitation Following Implantation of a Pacemaker/Cardioverter-Defibrillator

Abstract 8803: Bioprosthetic Tricuspid Valve Regurgitation Associated with Device Lead Implantation

Outcomes following permanent pacemaker implantation in patients undergoing tricuspid valve surgery

A meta‐analysis of the distance between lead‐implanted site and tricuspid valve annulus with postoperative tricuspid regurgitation deterioration in patients with left bundle branch area pacing